orforglipron semaglutide comparison Surpasses in GLP-1 Trial New Oral GLP-1 Orforglipron Receives

What this means: - HIIT can boost fitness and improve insulin resistance in people with diabesity - Benefits go beyond weight loss, and are important for long-term diabetes care - HIIT is a time-efficient, non-drug strategy that could complement standard treatments #Type2Diabetes #CardiometabolicHealth #HIIT #ClinicalResearch #NonPharmacological Read the full study: To view or add a comment, sign in What to Know About Semaglutide for Weight Loss Originally developed for type 2 diabetes, this FDA-approved medication helps regulate appetite and metabolismmaking it a powerful option for adults struggling with obesity or weight-related health issues

Semaglutide reduces appetite by activating GLP-1 receptors in the brain, helping patients lose an average of 1522% of body weight over 68 weeks according to clinical trials

It starts to work within 30 min after injection, and its action lasts up to 8 hours

Two doses is only 2 weeks in, which is not enough time to confirm GI tolerance or to settle into your titration step